Yinghua He

1.6k total citations
26 papers, 1.1k citations indexed

About

Yinghua He is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yinghua He has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Yinghua He's work include Epigenetics and DNA Methylation (10 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (7 papers). Yinghua He is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (7 papers). Yinghua He collaborates with scholars based in China, South Korea and United States. Yinghua He's co-authors include Kelong Ma, Jingde Zhu, Jun Gu, Xiaoying Luo, Hongyu Zhang, Daming Zhang, Wei Wang, Lei Lv, Shicheng Guo and Ying Cui and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Yinghua He

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinghua He China 18 905 634 148 95 78 26 1.1k
Daniela D’Angelo Italy 18 743 0.8× 578 0.9× 93 0.6× 78 0.8× 58 0.7× 30 1.0k
Quan Hao China 18 659 0.7× 574 0.9× 167 1.1× 72 0.8× 69 0.9× 37 994
Meng Xia China 13 486 0.5× 474 0.7× 126 0.9× 91 1.0× 59 0.8× 19 684
Chaofeng Ding China 18 833 0.9× 645 1.0× 143 1.0× 71 0.7× 116 1.5× 26 1.1k
Masaya Yonemori Japan 15 633 0.7× 494 0.8× 88 0.6× 76 0.8× 143 1.8× 30 802
Hengyu Li China 14 623 0.7× 520 0.8× 145 1.0× 67 0.7× 49 0.6× 28 838
Paloma del C. Monroig United States 9 832 0.9× 717 1.1× 95 0.6× 43 0.5× 47 0.6× 9 1.0k
Mengbin Li China 12 702 0.8× 501 0.8× 164 1.1× 106 1.1× 75 1.0× 23 906
Jie Ma China 19 757 0.8× 619 1.0× 102 0.7× 52 0.5× 170 2.2× 56 955

Countries citing papers authored by Yinghua He

Since Specialization
Citations

This map shows the geographic impact of Yinghua He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinghua He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinghua He more than expected).

Fields of papers citing papers by Yinghua He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinghua He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinghua He. The network helps show where Yinghua He may publish in the future.

Co-authorship network of co-authors of Yinghua He

This figure shows the co-authorship network connecting the top 25 collaborators of Yinghua He. A scholar is included among the top collaborators of Yinghua He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinghua He. Yinghua He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yinghua, Can Chen, Xiaobao Zhang, et al.. (2025). Epidemiological trends of hepatitis C incidence and death in Mainland China between 2004 and 2018 and its predictions to 2030. BMC Infectious Diseases. 25(1). 483–483.
2.
Chun, Jonghoon, et al.. (2024). Beyond the desk: Enhancing user satisfaction with contactless services in South Korean academic libraries. The Journal of Academic Librarianship. 51(1). 102986–102986.
3.
Ring, Huijun Z., et al.. (2024). Exploring Combined Immune Mechanisms of Acupuncture and Stretching—A Narrative Review. Health. 16(12). 1268–1288. 2 indexed citations
4.
Zhang, Shuo, et al.. (2019). Small Intestine Protection of Mica Against Non-Steroidal Anti-Inflammatory Drugs-Injury Through ERK1/2 Signal Pathway in Rats. Frontiers in Pharmacology. 10. 871–871. 2 indexed citations
5.
Li, Mingfang, Yuhuan Li, Yinghua He, et al.. (2018). Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC. Biomedicine & Pharmacotherapy. 99. 848–858. 40 indexed citations
6.
He, Yinghua, et al.. (2018). Molecular mechanisms of the action of Arctigenin in cancer. Biomedicine & Pharmacotherapy. 108. 403–407. 68 indexed citations
7.
Xu, Tao, Yinghua He, Mingquan Wang, et al.. (2016). Therapeutic potential of cysteine-rich protein 61 in rheumatoid arthritis. Gene. 592(1). 179–185. 11 indexed citations
8.
Liu, Qi, Cheng Zhang, Xianting Ding, et al.. (2015). Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform. Scientific Reports. 5(1). 11464–11464. 17 indexed citations
9.
Ma, Kelong, Xiaorong Pan, Pingsheng Fan, et al.. (2014). Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells. Molecular Cancer. 13(1). 118–118. 62 indexed citations
10.
Deng, Hui, Lei Lv, Yang Li, et al.. (2014). miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway. Molecular Cancer. 13(1). 234–234. 75 indexed citations
11.
Lv, Lei, Han‐Xiang Deng, Daming Zhang, et al.. (2014). The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression. Cell Death and Disease. 5(9). e1402–e1402. 95 indexed citations
12.
Lv, Lei, Yang Li, Hui Deng, et al.. (2014). MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene. Cancer Letters. 357(1). 105–113. 57 indexed citations
14.
He, Yinghua, et al.. (2014). Hypermethylation Leads to Bone Morphogenetic Protein 6 Downregulation in Hepatocellular Carcinoma. PLoS ONE. 9(1). e87994–e87994. 13 indexed citations
15.
Zhao, Yangxing, Hua‐Fu Zhou, Kelong Ma, et al.. (2013). Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer. Oncology Letters. 5(4). 1211–1218. 38 indexed citations
17.
Yu, Wei, Chengmeng Jin, Xiaoyan Lou, et al.. (2011). Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell. PLoS ONE. 6(12). e29450–e29450. 54 indexed citations
18.
Sun, Jinfeng, Chen Zhou, Tongyu Zhu, et al.. (2009). Hypermethylated SFRP1, but none of other nine genes “informative” for western countries, is valuable for bladder cancer detection in mainland China. Journal of Cancer Research and Clinical Oncology. 135(12). 1717–1727. 19 indexed citations
19.
Lin, Qiang, Junfeng Geng, Kelong Ma, et al.. (2009). RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. Journal of Cancer Research and Clinical Oncology. 135(12). 1675–1684. 47 indexed citations
20.
He, Yinghua, et al.. (2008). A stringent dual control system overseeing transcription and activity of the Cre recombinase for the liver-specific conditional gene knock-out mouse model. Journal of genetics and genomics. 35(7). 431–439. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026